177 related articles for article (PubMed ID: 2421644)
21. Immunogenicity of melanoma-associated gangliosides in cancer patients.
Tai T; Cahan LD; Tsuchida T; Saxton RE; Irie RF; Morton DL
Int J Cancer; 1985 May; 35(5):607-12. PubMed ID: 3997282
[TBL] [Abstract][Full Text] [Related]
22. Purification and structural characterization of de-N-acetylated form of GD3 ganglioside present in human melanoma tumors.
Popa I; Pons A; Mariller C; Tai T; Zanetta JP; Thomas L; Portoukalian J
Glycobiology; 2007 Apr; 17(4):367-73. PubMed ID: 17242043
[TBL] [Abstract][Full Text] [Related]
23. Generation of murine monoclonal antibodies specific for N-glycolylneuraminic acid-containing gangliosides.
Ozawa H; Kawashima I; Tai T
Arch Biochem Biophys; 1992 May; 294(2):427-33. PubMed ID: 1567198
[TBL] [Abstract][Full Text] [Related]
24. A monoclonal antibody recognizes an O-acylated sialic acid in a human melanoma-associated ganglioside.
Cheresh DA; Varki AP; Varki NM; Stallcup WB; Levine J; Reisfeld RA
J Biol Chem; 1984 Jun; 259(12):7453-9. PubMed ID: 6203895
[TBL] [Abstract][Full Text] [Related]
25. Heterophile Hanganutziu-Deicher antigen in ganglioside fractions of human melanoma tissues.
Kawachi S; Saida T; Uhara H; Uemura K; Taketomi T; Kano K
Int Arch Allergy Appl Immunol; 1988; 85(3):381-3. PubMed ID: 3258290
[TBL] [Abstract][Full Text] [Related]
26. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
[TBL] [Abstract][Full Text] [Related]
27. Isolation and characterization of gangliosides from Theileria sergenti.
Watarai S; Sugimoto C; Hosotani-Kaihara K; Kobayashi K; Onuma M; Lee JT; Kushi Y; Handa S; Yasuda T
J Vet Med Sci; 1996 Nov; 58(11):1099-105. PubMed ID: 8959658
[TBL] [Abstract][Full Text] [Related]
28. Fluctuations in the expression of a glycolipid antigen associated with differentiation of melanoma cells monitored by a monoclonal antibody, Leo Mel 3.
Werkmeister JA; Triglia T; Mackay IR; Dowling JP; Varigos GA; Morstyn G; Burns GF
Cancer Res; 1987 Jan; 47(1):225-30. PubMed ID: 3791209
[TBL] [Abstract][Full Text] [Related]
29. Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N-glycolylneuraminic acid-containing gangliosides.
Watarai S; Kushi Y; Shigeto R; Misawa N; Eishi Y; Handa S; Yasuda T
J Biochem; 1995 May; 117(5):1062-9. PubMed ID: 8586620
[TBL] [Abstract][Full Text] [Related]
30. Delineation of the epitope recognized by an antibody specific for N-glycolylneuraminic acid-containing gangliosides.
Moreno E; Lanne B; Vázquez AM; Kawashima I; Tai T; Fernández LE; Karlsson KA; Angström J; Pérez R
Glycobiology; 1998 Jul; 8(7):695-705. PubMed ID: 9621110
[TBL] [Abstract][Full Text] [Related]
31. Incorporation, remodeling and re-expression of exogenous gangliosides in human cancer cell lines in vitro and in vivo.
Nishio M; Furukawa K
Nagoya J Med Sci; 2004 May; 67(1-2):35-44. PubMed ID: 15279066
[TBL] [Abstract][Full Text] [Related]
32. [Spectrum pattern and determination of ganglioside from human primary liver cancer of different origins].
Lin ZY
Zhonghua Zhong Liu Za Zhi; 1990 Sep; 12(5):336-8. PubMed ID: 2276322
[TBL] [Abstract][Full Text] [Related]
33. Determination of N-acetyl- and N-glycolylneuraminic acids in gangliosides by combination of neuraminidase hydrolysis and fluorometric high-performance liquid chromatography using a GM3 derivative as an internal standard.
Hikita T; Tadano-Aritomi K; Iida-Tanaka N; Toyoda H; Suzuki A; Toida T; Imanari T; Abe T; Yanagawa Y; Ishizuka I
Anal Biochem; 2000 Jun; 281(2):193-201. PubMed ID: 10870835
[TBL] [Abstract][Full Text] [Related]
34. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
35. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
[TBL] [Abstract][Full Text] [Related]
36. Molecular cloning of a human monoclonal antibody reactive to ganglioside GM3 antigen on human cancers.
Hoon DS; Wang Y; Sze L; Kanda H; Watanabe T; Morrison SL; Morton DL; Irie RF
Cancer Res; 1993 Nov; 53(21):5244-50. PubMed ID: 7916649
[TBL] [Abstract][Full Text] [Related]
37. [Mouse monoclonal antibodies recognizing melanoma-associated ganglioside antigens].
Hirabayashi Y; Matsumoto M; Taniguchi M
Seikagaku; 1985 Oct; 57(10):1385-90. PubMed ID: 2418135
[No Abstract] [Full Text] [Related]
38. [Detection of gangliosides in human milk with a high performance thin layer chromatography (HPTLC)].
Pan X; Hua T; Wu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Mar; 35(2):111-3. PubMed ID: 11413682
[TBL] [Abstract][Full Text] [Related]
39. Immunorecognition of different ganglioside epitopes on human normal and melanoma tissues.
Bernhard H; Roth S; Bauerschmitz J; Meyer zum Büschenfelde KH; Dippold W
Int J Cancer; 1992 Jun; 51(4):568-72. PubMed ID: 1376299
[TBL] [Abstract][Full Text] [Related]
40. N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome.
Odaka M; Yuki N; Yoshino H; Kasama T; Handa S; Irie F; Hirabayashi Y; Suzuki A; Hirata K
Ann Neurol; 1998 Jun; 43(6):829-34. PubMed ID: 9629854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
